Skip to main content

CX Institutional

SEC CIK
0001737089
Latest filing
Oct 2, 2026

BCRX holding history

Biocryst Pharmaceuticals Inc in every 13F filed by CX Institutional, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BCRX overviewAll 13F holders of BCRXFull Q3 2026 holdings

Shares (Q3 2022)
0
Sold out in Q3 2022
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q2 2022
Holdings of BCRX by CX Institutional, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20220$00.0%−1,760−100.0%Sold outHolders
Q2 20221,760$19.0K<0.1%+1,760NewHolders